July 9, 2026 · Form 4 insider transaction
Ellis Andrea sold 17,167 shares of BridgeBio Pharma, Inc. at $84.00 per share, a transaction worth $1.44M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.